Surgical Science Sweden AB (publ) (SUSRF)
Surgical Science Sweden AB engages in the development of simulators for laparoscopic medical training. Its products include LapSim, for procedural simulation for cholecystectomy, appendectomy, advanced suturing and anastomosis, gynecology, hysterectomy, bariatrics, and nephrectomy; EndoSim, for endoscopy simulation; and TeamSim, for realistic training of collaboration within a surgery team. The company was founded by Anders Hyltander, David Löfstrand, and Anders Larsson on July 24, 1997 and is headquartered in Gothenburg, Sweden.
Sector: Medical - Healthcare Information Services
Industry: Medical - Healthcare Information Services
Surgical Science Sweden AB (publ)
- Not computed: no float on record for this company.
- 80.0K
- 999.99
The cost to borrow SUSRF shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.
- No fails on record for 16–31 Oct 2026.
Latest short interest settlements (today's share basis)
| Date | Shares short |
|---|---|
| Oct 30, 2026 | 80.0K sh |
| Oct 15, 2026 | 116.2K sh |
| Sep 30, 2026 | 119.0K sh |
| Sep 15, 2026 | 128.9K sh |
| Aug 31, 2026 | 176.1K sh |
The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.
Too few published sessions to show a reading in context.
FINRA's weekly alternative trading system (dark pool) volume for SUSRF: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.
As of the Oct 30, 2026 FINRA settlement, 80,049 SUSRF shares were sold short (999.99 days to cover).